A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
OBJECTIVE: To compare the potential of two diagnostic methods for detecting recurrence of urothelial cell carcinoma (UCC) of the bladder, by (i) detecting alterations in microsatellite DNA markers and loss of heterozygosity (LOH), and (ii) detecting aberrant gene hypermethylation, as UCC has a high...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1826266602155278336 |
|---|---|
| author | Rouprêt, M Hupertan, V Yates, DR Comperat, E Catto, J Meuth, M Lackmichi, A Ricci, S Lacave, R Gattegno, B Richard, F Hamdy, F Cussenot, O |
| author_facet | Rouprêt, M Hupertan, V Yates, DR Comperat, E Catto, J Meuth, M Lackmichi, A Ricci, S Lacave, R Gattegno, B Richard, F Hamdy, F Cussenot, O |
| author_sort | Rouprêt, M |
| collection | OXFORD |
| description | OBJECTIVE: To compare the potential of two diagnostic methods for detecting recurrence of urothelial cell carcinoma (UCC) of the bladder, by (i) detecting alterations in microsatellite DNA markers and loss of heterozygosity (LOH), and (ii) detecting aberrant gene hypermethylation, as UCC has a high recurrence rate in the urinary tract and the disease can invade muscle if new tumours are overlooked. PATIENTS AND METHODS: Over 1 year, urine samples were retrieved from 40 patients already diagnosed with bladder UCC (30 pTa, two pTis, eight pT1). Samples were collected 6 months after bladder tumour resection, during the follow-up schedule. We used samples to analyse nine microsatellite markers and the methylation status of 11 gene promoters. Receiver operating characteristic curves were generated and Bayesian statistics used to create an interaction network between recurrence and the biomarkers. RESULTS: During the study, 15 of the 40 patients (38%) had a tumour recurrence and 14 were identified by cystoscopy (reference method). Overall, microsatellite markers (area under curve, AUC 0.819, 95% confidence interval, CI, 0.677-0.961) had better performance characteristics than promoter hypermethylation (AUC 0.448, 0.259-0.637) for detecting recurrence. A marker panel of IFNA, MBP, ACTBP2, D9S162 and of RASSF1A, and WIF1 generated a higher diagnostic accuracy of 86% (AUC 0.92, 0.772-0.981). CONCLUSION: Microsatellite markers have better performance characteristics than promoter hypermethylation for detecting UCC recurrence. These data support the further development of a combination of only six markers from both methods in urinary DNA. Once validated, it could be used routinely during the follow-up for the early detection and surveillance of UCC from the lower and upper urinary tract. |
| first_indexed | 2024-03-06T20:41:26Z |
| format | Journal article |
| id | oxford-uuid:346bcf91-97f3-47be-ad13-c28a41ab03a3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:41:26Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:346bcf91-97f3-47be-ad13-c28a41ab03a32022-03-26T13:25:52ZA comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:346bcf91-97f3-47be-ad13-c28a41ab03a3EnglishSymplectic Elements at Oxford2008Rouprêt, MHupertan, VYates, DRComperat, ECatto, JMeuth, MLackmichi, ARicci, SLacave, RGattegno, BRichard, FHamdy, FCussenot, O OBJECTIVE: To compare the potential of two diagnostic methods for detecting recurrence of urothelial cell carcinoma (UCC) of the bladder, by (i) detecting alterations in microsatellite DNA markers and loss of heterozygosity (LOH), and (ii) detecting aberrant gene hypermethylation, as UCC has a high recurrence rate in the urinary tract and the disease can invade muscle if new tumours are overlooked. PATIENTS AND METHODS: Over 1 year, urine samples were retrieved from 40 patients already diagnosed with bladder UCC (30 pTa, two pTis, eight pT1). Samples were collected 6 months after bladder tumour resection, during the follow-up schedule. We used samples to analyse nine microsatellite markers and the methylation status of 11 gene promoters. Receiver operating characteristic curves were generated and Bayesian statistics used to create an interaction network between recurrence and the biomarkers. RESULTS: During the study, 15 of the 40 patients (38%) had a tumour recurrence and 14 were identified by cystoscopy (reference method). Overall, microsatellite markers (area under curve, AUC 0.819, 95% confidence interval, CI, 0.677-0.961) had better performance characteristics than promoter hypermethylation (AUC 0.448, 0.259-0.637) for detecting recurrence. A marker panel of IFNA, MBP, ACTBP2, D9S162 and of RASSF1A, and WIF1 generated a higher diagnostic accuracy of 86% (AUC 0.92, 0.772-0.981). CONCLUSION: Microsatellite markers have better performance characteristics than promoter hypermethylation for detecting UCC recurrence. These data support the further development of a combination of only six markers from both methods in urinary DNA. Once validated, it could be used routinely during the follow-up for the early detection and surveillance of UCC from the lower and upper urinary tract. |
| spellingShingle | Rouprêt, M Hupertan, V Yates, DR Comperat, E Catto, J Meuth, M Lackmichi, A Ricci, S Lacave, R Gattegno, B Richard, F Hamdy, F Cussenot, O A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title | A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title_full | A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title_fullStr | A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title_full_unstemmed | A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title_short | A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. |
| title_sort | comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma and definition of a set of markers by bayesian network analysis |
| work_keys_str_mv | AT roupretm acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT hupertanv acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT yatesdr acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT comperate acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT cattoj acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT meuthm acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT lackmichia acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT riccis acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT lacaver acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT gattegnob acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT richardf acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT hamdyf acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT cussenoto acomparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT roupretm comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT hupertanv comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT yatesdr comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT comperate comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT cattoj comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT meuthm comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT lackmichia comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT riccis comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT lacaver comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT gattegnob comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT richardf comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT hamdyf comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis AT cussenoto comparisonoftheperformanceofmicrosatelliteandmethylationurineanalysisforpredictingtherecurrenceofurothelialcellcarcinomaanddefinitionofasetofmarkersbybayesiannetworkanalysis |